Coronary CT Angiogram - Prognostic Value of Adverse Plaque Features in Guiding Treatment (CT-PLAQUE)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

22000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-01-29

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study aims at determining if the presence of adverse plaque features identified from the CT angiogram can help determine prognosis and guide treatment options.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The AIPLAQUE Study: An Artificial Intelligence-based Prospective Study to Analyze PLAQUE Using CCTA

NCT05750082

Coronary Artery Disease Acute Coronary Syndrome Myocardial Ischemia Plaque Characterization

UNKNOWN

Impact of Coronary CT Angiography, Physiologic Assessment and Pharmacotherapy on the Clinical Outcomes

NCT04547231

Coronary Artery Disease

RECRUITING

Identification Of High-risk Coronary Plaques By Multimodal Intravascular Imaging

NCT06681155

Coronary Arterial Disease (CAD) Acute Coronary Syndromes

NOT_YET_RECRUITING

Risk Factors and Outcomes in Coronary Chronic Total Occlusion

NCT06137521

Chronic Total Occlusion Coronary Artery Disease

RECRUITING

Non-invasive and Invasive Plaque Characterisation

NCT01833338

Non ST Elevation Myocardial Infarction

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Determining if the Presence of Adverse Plaque Features Identified From the CT Angiogram Can Help Determining Prognosis and Guide Treatment Options

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patient who is ≥ 18 years old presented with chest pain and has undergone CTA before treatment

CTCA

Intervention Type DIAGNOSTIC_TEST

Patient who is ≥ 18 years old presented with chest pain and has undergone CTA between 01-Jan-2012 and 31-Dec-2022 before treatment

\- If multiple CTAs are taken, the most updated one before treatment commencement will be chosen.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CTCA

Patient who is ≥ 18 years old presented with chest pain and has undergone CTA between 01-Jan-2012 and 31-Dec-2022 before treatment

\- If multiple CTAs are taken, the most updated one before treatment commencement will be chosen.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient who is ≥ 18 years old presented with chest pain and has undergone CTA between 01-Jan-2012 and 31-Dec-2022 before treatment
* If multiple CTAs are taken, the most updated one before treatment commencement will be chosen.

Exclusion Criteria

* Patient who did not undergo cardiac CT scan due to inability to undergo cardiac CT scanning, kidney failure (serum creatinine \>250 μmol/L or estimated glomerular filtration rate \<30 mL/min), major allergy to contrast.

Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No